Treating COVID-19 with NRICM101 and NRICM102 - Author's reply 2
Pharmacol Res
.
2022 Nov:185:106446.
doi: 10.1016/j.phrs.2022.106446.
Epub 2022 Sep 9.
Authors
Ming-Yung Lee
1
,
Yu-Hwei Tseng
2
,
Sunny Jui-Shan Lin
3
,
Yi-Chang Su
4
Affiliations
1
Department of Data Science and Big Data Analytics, Providence University, Taichung, Taiwan.
2
National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taipei, Taiwan.
3
Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
4
National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taipei, Taiwan. Electronic address: sychang@nricm.edu.tw.
PMID:
36096421
PMCID:
PMC9461231
DOI:
10.1016/j.phrs.2022.106446
No abstract available
Keywords:
COVID-19; NRICM102; Traditional Chinese Medicine, NRICM101.
Publication types
Letter
MeSH terms
Acupuncture Therapy*
COVID-19*
Humans
Medicine, Chinese Traditional